Highland Clinic
Internal Medicine
Dr. Paul A. Rushing, MD
|
|
Give Review
Paul A. Rushing works in the field of Internal Medicine. He studied medicine at University of Arkansas for Medical Sciences. University of Arkansas for Medical Sciences has a rank of 83 in research and a 35 in primary care He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Diabetes Care Recognition". Paul Rushing has written publications. He has 36 publications published with PubMed. The lastest publication is: 'Prolongation of intermeal interval by gastrin-releasing peptide depends upon time of delivery.' Paul Rushing accepts Medicare payments and is listed with Medicare.gov.
Publications
- Consumption of a high-fat diet alters the homeostatic regulation of energy balance.
- Central amylin signaling and the regulation of energy homeostasis.
- A controlled high-fat diet induces an obese syndrome in rats.
- Altered feeding responses in mice with targeted disruption of the dopamine-3 receptor gene.
- Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences.
- Histamine H1 receptors mediate the anorectic action of the pancreatic hormone amylin.
- Inhibition of central amylin signaling increases food intake and body adiposity in rats.
- Neuropeptides and the control of energy homeostasis.
- The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats.
- Immediate and prolonged patterns of Agouti-related peptide-(83--132)-induced c-Fos activation in hypothalamic and extrahypothalamic sites.
- Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection.
- Attenuation of the anorectic effects of cholecystokinin and bombesin by the specific amylin antagonist AC 253.
- Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade.
- A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences.
- Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression.
- The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.
- Amylin receptors mediate the anorectic action of salmon calcitonin (sCT).
- Amylin and insulin interact to reduce food intake in rats.
- Amylin: a novel action in the brain to reduce body weight.
- Role of the CNS melanocortin system in the response to overfeeding.
- Gastrin-releasing peptide suppresses independent but not intraoral intake.
- Prolongation of intermeal interval by gastrin-releasing peptide depends upon time of delivery.
- Prolongation of the postprandial intermeal interval by gastrin-releasing peptide1-27 in spontaneously feeding rats.
- Spontaneous and scheduled eating: microstructural and peptide effects.
- High lick rate is maintained throughout spontaneous liquid meals in freely feeding rats.
- Acute administration of phenylpropanolamine fails to affect resting energy expenditure in men of normal weight.
- Gastrin-releasing peptide1-27, unlike bombesin, does not reduce sham feeding in rats.
- Brief, meal-contingent infusions of gastrin-releasing peptide1-27 and neuromedin B-10 inhibit spontaneous feeding in rats.
- Vena caval bombesin infusion decreases spontaneous meal size in undisturbed rats.
- Effects of chronic phenylpropanolamine infusion and termination on body weight, food consumption and water consumption in rats.
- Lack of involvement of 4-hydroxynorephedrine in phenylpropanolamine-induced anorexia in rats.
- Effects of phenylpropanolamine infusion and withdrawal on body weight and dietary composition in male and female rats.
- Effects of phenylpropanolamine on regulatory and nonregulatory ingestion in adult rats.
- Effects of nicotine cycling on weight loss and regain in male rats.
- Discharging ICU ventilator-dependent patients to home healthcare.
Schools
Louisiana State University School Of Medicine In Shreveport
University Of Ar College Of Med
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Diabetes Care Recognition
Education
-
University of Arkansas for Medical Sciences -
Louisiana State University School of Medicine in Shreveport
Drug Facts
| NPI NUMBER | 1003810904 | |
| NPPES Provider LastName | RUSHING | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 711055634 | |
| NPPES Provider State | LA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 10757.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 365.0 | |
| Percent Opioid Claims | 3.39 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003810904 |
| Last Name Of The Provider | RUSHING |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Richard E. Haynie, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amanda V. Jimenez, MD |
|
|
Dr. Sesha K. Sataluri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren E. Juneja, MD |
|
|
Dr. Pavan K. Katikaneni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheel J. Patel, MD |
|
|
Dr. Kamal Bhusal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam H. Wells, MD |
|
|
Dr. Matthew C. Frank, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen H. Erickstad, MD |
|
|
Sanjay R. Jain, MB BS |